RCMI Coordinating Center (RCMI CC) Header Logo

Lilly Immergluck

Title
Faculty RankProfessor
InstitutionMorehouse School of Medicine
DepartmentMicrobiology, Biochemistry, & Immunology
Address720 Westveiw Drive, SW
Atlanta GA 30310
Phone4047561330
vCardDownload vCard
    Other Positions
    TitlePediatric Infectious Disease Specialist
    InstitutionChildren''s Healthcare of Atlanta

    TitleFellow
    InstitutionAmerican Academy of Pediatrics
    DepartmentSection on Infectious Diseases


    Collapse Biography 
    Collapse education and training
    Northwestern University, Evanston, ILB.A05/1986Biochemistry/Molecular and Cell Biology
    The Ohio State University College of Medicine, Columbus, OHMD06/1990Doctor of Medicine
    University of Chicago, Chicago, ILIntern06/1991Pediatrics
    University of Chicago, Chicago, ILResident Physician in Pediatrics06/1993Pediatrics
    NIH-University of Chicago, Chicago, ILFellow, Pediatric Scientist Development Program06/1996Infectious Diseases
    University of Chicago, Pediatric Infectious Diseases, Chicago, ILFellowship06/1996Pediatric Infectious Diseases
    Morehouse School of Medicine, Atlanta, GAM.S. C.R05/2013Clinical Research

    Collapse Overview 
    Collapse overview
    Dr. Lilly Immergluck is Associate Professor of Pediatrics at Morehouse School of Medicine and Pediatric Infectious Disease Specialist with Children’s Healthcare of Atlanta. Dr. Immergluck also holds a joint appointment as Assistant Professor in the Department of Microbiology/Biochemistry/Immunology at Morehouse School of Medicine.

    She received her B.A. degree from Northwestern University in Evanston, Illinois and received her medical degree from Ohio State University College of Medicine in 1990. She completed her residency in Pediatrics at the University of Chicago Children’s Hospital and also completed a fellowship in Pediatric Infectious Diseases at the University of Chicago. She was a recipient of the Pediatric Scientist Development Award in 1994, where she developed a primary neuronal model to study requirements for herpes simplex entry. In 2012, she received her Master’s of Science in Clinical Research.

    Prior to relocating to Atlanta in 2005, she was Assistant Professor of Pediatrics at the University of Illinois at Chicago from 1996-2002 and then Associate Professor of Pediatrics at Michigan State University and was Director of the Pediatric Infectious Diseases Program at DeVos Children’s Hospital from 2002-2005. For the past 15 years her clinical research endeavors have focused primarily on elucidating the risk factors and understanding the epidemiology of children who have been colonized or infected by the resistant bacterium, community-associated methicillin resistant Staphylococcus aureus (or CA-MRSA). She has an interest in hospital epidemiology and also public health matters as it relates to the prevention of infectious diseases among medically underserved populations and vaccine preventable conditions, including rotavirus, influenza, and pneumococcus. She currently is site director of the MRSA Treatment Center in Atlanta, which is part of a national NIH funded multi-center clinical trial to look at treatment options for uncomplicated skin and soft tissue infections and also is involved to look at the impact of rotavirus vaccinations on eliminating rotaviral related illnesses among infants and young children in the US.


    Collapse Research 
    Collapse research activities and funding
    K08HS024338     (IMMERGLUCK, LILLY HSI-CHIH)Sep 1, 2015 - Aug 31, 2021
    NIH
    Using a Novel Geospatial Statistical Model to Evaluate Specific Social and Ecological Determinants of Health in Children with Antibiotic Resistant Staphylococcal Infections
    Role: Principal Investigator
    G08LM013190     (IMMERGLUCK, LILLY HSI-CHIH)Aug 5, 2019 - Apr 30, 2022
    NIH
    Project HIRaCAARI: Empowering Communities to Stop the Spread of Antibiotic Resistant Infections through Accessible Health Information
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Fong Y, Dang L, Zhang B, Fintzi J, Chen S, Wang J, Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Yu C, Magaret CA, Molitor C, Borate B, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, B?cker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Mu J, Makowski M, Makhene MK, Nayak SU, Roberts PC, Follmann D, Gilbert PB. Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial. Clin Infect Dis. 2024 Sep 26. PMID: 39325506.
      Citations:    Fields:    
    2. Flores JM, Grills N, Kane JM, Immergluck LC, Kasal N, Kumar M, Bartlett AH. Describing the Heterogeneity of Clinical Utilization of Congenital Syphilis Diagnostic Modalities Among Major United States Tertiary Children's Hospitals, 2017-2022. Sex Transm Dis. 2024 Dec 01; 51(12):780-783. PMID: 39046167.
      Citations: 1     Fields:    Translation:Humans
    3. Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, B?cker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Netzl A, Smith DJ, Telu K, Mu J, McQuarrie LJ, Makowski M, Makhene MK, Crandon S, Montefiori DC, Roberts PC, Beigel JH. Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial. J Infect Dis. 2023 12 20; 228(12):1662-1666. PMID: 37561027.
      Citations:    Fields:    Translation:Humans
    4. Stephenson KE, Marcelin JR, Pettifor AE, Janes H, Brown E, Neradilek M, Yen C, Andriesen J, Grunenberg N, Espy N, Trahey M, Fischer RSB, DeSouza CA, Shisler JL, Connick E, Houpt ER, Chu HY, McCulloh RJ, Becker-Dreps S, Vielot NA, Kalbaugh CA, Cherabuddi K, Krueger KM, Rosenberg M, Greenberg RN, Joaquin A, Immergluck LC, Corey L, Kublin JG. Efficacy of Messenger RNA-1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021. Open Forum Infect Dis. 2023 Nov; 10(11):ofad511. PMID: 38023544.
      Citations:    
    5. Immergluck LC, Lin X, Geng R, Edelson M, Ali F, Li C, Lin TJ, Khalida C, Piper-Jenks N, Pardos de la Gandara M, de Lencastre H, Tomasz A, Evering TH, Kost RG, Vaughan R, Tobin JN. Molecular Epidemiologic and Geo-Spatial Characterization of Staphylococcus aureus Cultured from Skin and Soft Tissue Infections from United States-Born and Immigrant Patients Living in New York City. Antibiotics (Basel). 2023 Oct 14; 12(10). PMID: 37887242.
      Citations:    
    6. Flores J, Immergluck LC. Measles Update in an Era of Vaccine Hesitancy and Global Pandemic. Pediatr Rev. 2023 09 01; 44(9):529-532. PMID: 37653130.
      Citations:    Fields:    Translation:HumansPHPublic Health
    7. Branche AR, Rouphael NG, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Anderson EJ, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, B?cker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Malkin E, Bethony JM, Walsh EE, Graciaa DS, Samaha H, Sherman AC, Walsh SR, Abate G, Oikonomopoulou Z, El Sahly HM, Martin TCS, Kamidani S, Smith MJ, Ladner BG, Porterfield L, Dunstan M, Wald A, Davis T, Atmar RL, Mulligan MJ, Lyke KE, Posavad CM, Meagher MA, Stephens DS, Neuzil KM, Abebe K, Hill H, Albert J, Telu K, Mu J, Lewis TC, Giebeig LA, Eaton A, Netzl A, Wilks SH, T?reli S, Makhene M, Crandon S, Montefiori DC, Makowski M, Smith DJ, Nayak SU, Roberts PC, Beigel JH. Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial. Nat Med. 2023 09; 29(9):2334-2346. PMID: 37640860.
      Citations: 16     Fields:    Translation:HumansCellsCTClinical Trials
    8. Branche AR, Rouphael NG, Losada C, Baden LR, Anderson EJ, Luetkemeyer AF, Diemert DJ, Winokur PL, Presti RM, Kottkamp AC, Falsey AR, Frey SE, Rupp R, B?cker M, Novak RM, Walter EB, Jackson LA, Little SJ, Immergluck LC, Mahgoub SM, Whitaker JA, Babu TM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Netzl A, Smith DJ, Telu K, Mu J, Makowski M, Makhene MK, Crandon S, Montefiori DC, Roberts PC, Beigel JH. Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial. Clin Infect Dis. 2023 08 22; 77(4):560-564. PMID: 37036397.
      Citations: 6     Fields:    Translation:HumansCells
    9. Douglas MD, Li C, Josiah Willock R, Baltrus P, Caplan L, Immergluck L, McKinney T, Hopkins J, Mack D, Gaglioti AH. Population-Level Disparities in Exposure to COVID-19 Mitigation Policies, April 2020-April 2021. J Public Health Manag Pract. 2023 Nov-Dec 01; 29(6):874-881. PMID: 37498523.
      Citations: 1     Fields:    Translation:Humans
    10. Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, B?cker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Netzl A, Smith DJ, Telu K, Mu J, Makowski M, Makhene MK, Crandon S, Montefiori DC, Roberts PC, Beigel JH. Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial. medRxiv. 2023 Jun 10. PMID: 37333252.
      Citations:    
    11. Branche A, Rouphael N, Diemert D, Falsey A, Losada C, Baden LR, Frey S, Whitaker J, Little S, Anderson E, Walter E, Novak R, Rupp R, Jackson L, Babu T, Kottkamp A, Luetkemeyer A, Immergluck L, Presti R, Backer M, Winokur P, Mahgoub S, Goepfert P, Fusco D, Malkin E, Bethony J, Walsh E, Graciaa D, Samaha H, Sherman A, Walsh S, Abate G, Oikonomopoulou Z, El Sahly H, Martin T, Kamidani S, Smith M, Ladner B, Porterfield L, Dunstan M, Wald A, Davis T, Atmar R, Mulligan M, Lyke K, Posavad C, Meagher M, Stephens D, Neuzil K, Abebe K, Hill H, Albert J, Telu K, Mu J, Lewis T, Giebeig L, Eaton A, Netzl A, Wilks S, Tureli S, Makhene M, Crandon S, Montefiori D, Makowski M, Smith D, Nayak S, Roberts P, Beigel J. Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial. Res Sq. 2023 May 05. PMID: 37205592.
      Citations:    
    12. Lin X, Ali F, Leong T, Edelson M, Hampton S, Zuo Z, Li C, Rice C, Yan F, Baltrus PT, Randolph S, Immergluck LC. Influence of Mask Wearing during COVID-19 Surge and Non-Surge Time Periods in Two K-12 Public School Districts in Georgia, USA. Int J Environ Res Public Health. 2023 05 04; 20(9). PMID: 37174233.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    13. Branche AR, Rouphael NG, Losada C, Baden LR, Anderson EJ, Luetkemeyer AF, Diemert DJ, Winokur PL, Presti RM, Kottkamp AC, Falsey AR, Frey SE, Rupp R, B?cker M, Novak RM, Walter EB, Jackson LA, Little SJ, Immergluck LC, Mahgoub SM, Whitaker JA, Babu TM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Netzl A, Smith DJ, Telu K, Mu J, Makowski M, Makhene MK, Sonja C, Montefiori DC, Roberts PC, Beigel JH. Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial. medRxiv. 2023 Mar 31. PMID: 37034641.
      Citations:    
    14. Immergluck LC, Geng R, Li C, Edelson M, Lin X, Waller LA, Rust G, Xu J, Leong T, Baltrus P. Space-time trends of community-onset Staphylococcus aureus infections in children: a group-based trajectory modeling approach. Ann Epidemiol. 2023 06; 82:45-53.e1. PMID: 36905976.
      Citations:    Fields:    Translation:HumansCells
    15. Frndak S, Yan F, Edelson M, Immergluck LC, Kordas K, Idris MY, Dickinson-Copeland CM. Predicting Low-Level Childhood Lead Exposure in Metro Atlanta Using Ensemble Machine Learning of High-Resolution Raster Cells. Int J Environ Res Public Health. 2023 03 02; 20(5). PMID: 36901487.
      Citations: 1     Fields:    Translation:Humans
    16. Branche AR, Rouphael NG, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Anderson EJ, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, B?cker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Malkin E, Bethony JM, Walsh EE, Graciaa DS, Samaha H, Sherman AC, Walsh SR, Abate G, Oikonomopoulou Z, El Sahly HM, Martin TCS, Rostad CA, Smith MJ, Ladner BG, Porterfield L, Dunstan M, Wald A, Davis T, Atmar RL, Mulligan MJ, Lyke KE, Posavad CM, Meagher MA, Stephens DS, Neuzil KM, Abebe K, Hill H, Albert J, Lewis TC, Giebeig LA, Eaton A, Netzl A, Wilks SH, T?reli S, Makhene M, Crandon S, Lee M, Nayak SU, Montefiori DC, Makowski M, Smith DJ, Roberts PC, Beigel JH. SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses. medRxiv. 2022 Jul 15. PMID: 35898343.
      Citations:    
    17. Atwater AQ, Immergluck LC, Davidson AJ, Castanon-Cervantes O. Shift Work Predicts Increases in Lipopolysaccharide-Binding Protein, Interleukin-10, and Leukocyte Counts in a Cross-Sectional Study of Healthy Volunteers Carrying Low-Grade Systemic Inflammation. Int J Environ Res Public Health. 2021 12 14; 18(24). PMID: 34948768.
      Citations: 7     Fields:    Translation:Humans
    18. Dickinson-Copeland CM, Immergluck LC, Britez M, Yan F, Geng R, Edelson M, Kendrick-Allwood SR, Kordas K. Increased Risk of Sub-Clinical Blood Lead Levels in the 20-County Metro Atlanta, Georgia Area-A Laboratory Surveillance-Based Study. Int J Environ Res Public Health. 2021 05 13; 18(10). PMID: 34068063.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    19. Lundy SR, Richardson S, Ramsey A, Ellerson D, Fengxia Y, Onyeabor S, Kirlin W, Thompson W, Black CM, DeBruyne JP, Davidson AJ, Immergluck LC, Blas-Machado U, Eko FO, Igietseme JU, He Q, Omosun YO. Author Correction: Shift work influences the outcomes of Chlamydia infection and pathogenesis. Sci Rep. 2020 Dec 11; 10(1):22183. PMID: 33311582.
      Citations:    Fields:    
    20. Lundy SR, Richardson S, Ramsey A, Ellerson D, Fengxia Y, Onyeabor S, Kirlin W, Thompson W, Black CM, DeBruyne JP, Davidson AJ, Immergluck LC, Blas-Machado U, Eko FO, Igietseme JU, He Q, Omosun YO. Shift work influences the outcomes of Chlamydia infection and pathogenesis. Sci Rep. 2020 09 21; 10(1):15389. PMID: 32958779.
      Citations: 3     Fields:    Translation:AnimalsCells
    21. She Z, Gaglioti AH, Baltrus P, Li C, Moore MA, Immergluck LC, Rao A, Ayer T. Primary Care Comprehensiveness and Care Coordination in Robust Specialist Networks Results in Lower Emergency Department Utilization: A Network Analysis of Medicaid Physician Networks. J Prim Care Community Health. 2020 Jan-Dec; 11:2150132720924432. PMID: 32507022.
      Citations: 7     Fields:    Translation:Humans
    22. Ali F, Immergluck LC, Leong T, Waller L, Malhotra K, Jerris RC, Edelson M, Rust GS. A Spatial Analysis of Health Disparities Associated with Antibiotic Resistant Infections in Children Living in Atlanta (2002-2010). EGEMS (Wash DC). 2019 Sep 12; 7(1):50. PMID: 31565665.
      Citations:    
    23. Ofili EO, Schanberg LE, Hutchinson B, Sogade F, Fergus I, Duncan P, Hargrove J, Artis A, Onyekwere O, Batchelor W, Williams M, Oduwole A, Onwuanyi A, Ojutalayo F, Cross JA, Seto TB, Okafor H, Pemu P, Immergluck L, Foreman M, Mensah EA, Quarshie A, Mubasher M, Baker A, Ngare A, Dent A, Malouhi M, Tchounwou P, Lee J, Hayes T, Abdelrahim M, Sarpong D, Fernandez-Repollet E, Sodeke SO, Hernandez A, Thomas K, Dennos A, Smith D, Gbadebo D, Ajuluchikwu J, Kong BW, McCollough C, Weiler SR, Natter MD, Mandl KD, Murphy S. The Association of Black Cardiologists (ABC) Cardiovascular Implementation Study (CVIS): A Research Registry Integrating Social Determinants to Support Care for Underserved Patients. Int J Environ Res Public Health. 2019 05 10; 16(9). PMID: 31083298.
      Citations: 5     Fields:    Translation:Humans
    24. Immergluck LC, Leong T, Malhotra K, Parker TC, Ali F, Jerris RC, Rust GS. Correction to: Geographic surveillance of community associated MRSA infections in children using electronic health record data. BMC Infect Dis. 2019 May 09; 19(1):396. PMID: 31072308.
      Citations: 1     Fields:    
    25. Immergluck LC, Leong T, Malhotra K, Parker TC, Ali F, Jerris RC, Rust GS. Geographic surveillance of community associated MRSA infections in children using electronic health record data. BMC Infect Dis. 2019 Feb 18; 19(1):170. PMID: 30777016.
      Citations: 18     Fields:    Translation:HumansCellsPHPublic Health
    26. Fareed S, Sarode N, Stewart FJ, Malik A, Laghaie E, Khizer S, Yan F, Pratte Z, Lewis J, Immergluck LC. Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children. PeerJ. 2018; 6:e4663. PMID: 29868248.
      Citations: 11     Fields:    
    27. Daum RS, Miller LG, Immergluck L, Fritz S, Creech CB, Young D, Kumar N, Downing M, Pettibone S, Hoagland R, Eells SJ, Boyle MG, Parker TC, Chambers HF. A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses. N Engl J Med. 2017 06 29; 376(26):2545-2555. PMID: 28657870.
      Citations: 50     Fields:    Translation:HumansCells
    28. Immergluck LC, Jain S, Ray SM, Mayberry R, Satola S, Parker TC, Yuan K, Mohammed A, Jerris RC. Risk of Skin and Soft Tissue Infections among Children Found to be Staphylococcus aureus MRSA USA300 Carriers. West J Emerg Med. 2017 Feb; 18(2):201-212. PMID: 28210352.
      Citations: 10     Fields:    Translation:HumansCells
    29. Mijatovic-Rustempasic S, Immergluck LC, Parker TC, Laghaie E, Mohammed A, McFadden T, Parashar UD, Bowen MD, Cortese MM. Shedding of porcine circovirus type 1 DNA and rotavirus RNA by infants vaccinated with Rotarix?. Hum Vaccin Immunother. 2017 04 03; 13(4):928-935. PMID: 27936349.
      Citations: 8     Fields:    Translation:HumansCells
    30. Parker TC, Mohammed A, Leong T, Mays S, Jain S, Churchill V, Ali F, Immergluck LC. Rotavirus vaccination rate disparities seen among infants with acute gastroenteritis in Georgia. Ethn Health. 2017 12; 22(6):585-595. PMID: 27741577.
      Citations:    Fields:    Translation:HumansPHPublic Health
    31. Baltrus P, Xu J, Immergluck L, Gaglioti A, Adesokan A, Rust G. Individual and county level predictors of asthma related emergency department visits among children on Medicaid: A multilevel approach. J Asthma. 2017 01 02; 54(1):53-61. PMID: 27285734.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    32. Immergluck LC, Parker TC, Jain S, Laghaie E, Spandorfer P, Jerris RC, Bowen MD, Parashar UD, Cortese MM. Sustained Effectiveness of Monovalent and Pentavalent Rotavirus?Vaccines in Children. J Pediatr. 2016 05; 172:116-120.e1. PMID: 26935786.
      Citations: 10     Fields:    Translation:HumansCells
    33. Mohammed A, Immergluck L, Parker TC, Jain S, Leong T, Anderson EJ, Jerris RC. Association between mixed rotavirus vaccination types of infants and rotavirus acute gastroenteritis. Vaccine. 2015 Oct 13; 33(42):5670-5677. PMID: 26322843.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    34. Malhotra K, Baltrus P, Zhang S, McRoy L, Immergluck LC, Rust G. Geographic and racial variation in asthma prevalence and emergency department use among Medicaid-enrolled children in 14 southern states. J Asthma. 2014 Nov; 51(9):913-21. PMID: 24915006.
      Citations: 20     Fields:    Translation:Humans
    35. Cortese MM, Immergluck LC, Held M, Jain S, Chan T, Grizas AP, Khizer S, Barrett C, Quaye O, Mijatovic-Rustempasic S, Gautam R, Bowen MD, Moore J, Tate JE, Parashar UD, V?zquez M. Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics. 2013 Jul; 132(1):e25-33. PMID: 23776114.
      Citations: 54     Fields:    Translation:Humans
    36. Immergluck LC, Satola SW, Jain S, McCracken C, Watson JR, Chan T, Leong T, Gottlieb E, Jerris RC. Methicillin-resistant Staphylococcus aureus colonization among pediatric health care workers from different outpatient settings. Am J Infect Control. 2013 Sep; 41(9):841-3. PMID: 23433983.
      Citations: 2     Fields:    Translation:HumansCells
    37. Cortese MM, Leblanc J, White KE, Jerris RC, Stinchfield P, Preston KL, Meek J, Odofin L, Khizer S, Miller CA, Buttery V, Mijatovic-Rustempasic S, Lewis J, Parashar UD, Immergluck LC. Leveraging state immunization information systems to measure the effectiveness of rotavirus vaccine. Pediatrics. 2011 Dec; 128(6):e1474-81. PMID: 22084328.
      Citations: 16     Fields:    Translation:Humans
    38. Immergluck LC. Community-associated infections in children--update on community-associated methicillin-resistant Staphylococcus aureus for the practitioner. Ethn Dis. 2007; 17(2 Suppl 2):S2-46-9. PMID: 17684814.
      Citations: 2     Fields:    Translation:HumansCells
    39. Immergluck LC, Cull WL, Schwartz A, Elstein AS. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago. Pediatrics. 2000 Apr; 105(4):E54. PMID: 10742375.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    40. Minutti CZ, Immergluck LC, Schmidt ML. Spontaneous gas gangrene due to Clostridium perfringens. Clin Infect Dis. 1999 Jan; 28(1):159-60. PMID: 10028101.
      Citations: 4     Fields:    Translation:HumansCells
    41. Immergluck LC, Domowicz MS, Schwartz NB, Herold BC. Viral and cellular requirements for entry of herpes simplex virus type 1 into primary neuronal cells. J Gen Virol. 1998 Mar; 79 ( Pt 3):549-59. PMID: 9519833.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    42. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, Leitch CD, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998 Feb 25; 279(8):593-8. PMID: 9486753.
      Citations: 425     Fields:    Translation:HumansCells
    43. Immergluck LC, Ben-Ami T, Herold BC. Thymic abscess caused by methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J. 1996 Jan; 15(1):96-7. PMID: 8684890.
      Citations:    Fields:    Translation:Humans
    Immergluck's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (154)
    Explore
    _
    Co-Authors (20)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support